Cargando…
Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
The complex pathogenesis of Alzheimer’s disease (AD) involves multiple contributing factors, including amyloid β (Aβ) peptide accumulation, inflammation and oxidative stress. Effective therapeutic strategies for AD are still urgently needed. Triptolide is the major active compound extracted from Tri...
Autores principales: | Wang, Qi, Xiao, Bing, Cui, Shuqin, Song, Hailong, Qian, Yanjing, Dong, Lin, An, Haiting, Cui, Yanqiu, Zhang, Wenjing, He, Yi, Zhang, Jianliang, Yang, Jian, Zhang, Feilong, Hu, Guanzheng, Gong, Xiaoli, Yan, Zhen, Zheng, Yan, Wang, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257007/ https://www.ncbi.nlm.nih.gov/pubmed/25481013 http://dx.doi.org/10.1242/dmm.018218 |
Ejemplares similares
-
EP2-PKA signaling is suppressed by triptolide in lipopolysaccharide-induced microglia activation
por: Zhang, Ting, et al.
Publicado: (2015) -
Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer’s Disease
por: Zhen, Junli, et al.
Publicado: (2017) -
Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells
por: YAN, XIAOMIN, et al.
Publicado: (2015) -
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
por: Yao, Annie Y., et al.
Publicado: (2023) -
Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model
por: Wang, Yaqi, et al.
Publicado: (2020)